Below are the most recent publications written about "Multicenter Studies as Topic" by people in Profiles.
-
Xiang Y, Yang S, Guo L, Dong C, Majoie CBLM, Siddiqui AH, Mocco J, Cavalcante F, Li BH, Wang JH, Huang B, Wang DZ, Yu NW, Schonewille WJ, Turk AS, Guo FQ. BEST-BAO: a multicentre, prospective, randomised controlled trial of endovascular treatment with or without intravenous thrombolysis in acute ischaemic stroke due to basilar artery occlusion - study protocol and rationale. Stroke Vasc Neurol. 2026 Jun 29; 11(3):358-364.
-
Dorbala S, Maurer MS, Cuddy SAM, Auer BD, Kijewski MF, Clerc OF, Khouri MG, Mitchell JD, Sperry BW, Hanna M, AbouEzzeddine OF, Malhotra S, Wall JS, Guthrie S, Di Carli MF, Ruberg FL, Dilsizian V, Dispenzieri A, Udelson JE, Narra RK, Masri AM. Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of 124I-evuzamitide to diagnose cardiac amyloidosis. J Nucl Cardiol. 2026 Jul; 61:102773.
-
De Leon E, De La Calle F, Mandal S, Rosal MC, Nay J, Colella D, Dapkins I, Schoenthaler A. Understanding Implementation of a Technology-Facilitated Hypertension Model in Federally Qualified Health Centers: A Realist Evaluation of Staff Experiences. J Gen Intern Med. 2026 Sep; 41(12):3451-3462.
-
Cassarly C, Ikramuddin S, Schlaug G, Salameh A, Wolf SL, Broderick JP, Feld JA, Fritz S, Rowe VT, Feng W. Transcranial Direct Current Stimulation for Stroke Motor Recovery: What the TRANSPORT2 Trial Taught Us. Stroke. 2026 Aug; 57(8):2510-2519.
-
Reynolds MR, Pollit V, Schwamm L, Witte KK, Yaghi S, Rose DZ, Cudworth S, Carpenter J, Rosemas SC, Ziegler PD, Neisen K, Franco NC, Bernstein RA. Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in large- or small-vessel disease ischaemic stroke in the USA. BMJ Open. 2026 Apr 27; 16(4):e103766.
-
Moon RY, Hwang SS, Hauck FR, Kellams AL, Shafer PR, Colvin BN, Karpman H, Carlin RF, Corwin MJ, Colson E, Parker MG. Get Social Media and Risk-Reduction Training (GET SMART) to improve infant safe sleep practices through a mobile text message-delivered video safe sleep intervention for new parents: study protocol for a type 3 hybrid implementation-effectiveness cluster randomized trial in 20 US birth hospitals. BMC Pediatr. 2026 03 11; 26(1).
-
Olszewski AE, Butler RA, Ashana DC, Carson S, Cox CE, Hough CL, Hwang DY, Maloney D, Mayr F, Menon V, Steingrub JS, Sullivan DR, Vincent G, Wendlandt B, White D. Protocol for a randomized trial of a scalable, interactive tool to support surrogate decision-makers of critically ill patients. Contemp Clin Trials. 2026 May; 164:108262.
-
Ostermann M, Corteville DC, Doi K, Koyner JL, Lamy A, Li G, Solinsky CM, Winterberg PD, Smith WT, Mehta RL, Murray PT, Shaw AD, Zarbock A, Engelman DT. A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS). Trials. 2025 May 30; 26(1):181.
-
Wainer AL, Edmunds SR, Carter AS, Stone WL, Sheldrick RC, Broder-Fingert S, Stern YS, Harrington E, V Ibanez L, Ingersoll B. A hybrid type I randomized effectiveness-implementation trial of a Naturalistic Developmental Behavioral Intervention in the Part C early intervention system: study protocol. BMC Pediatr. 2025 Apr 01; 25(1):263.
-
Ogdie A, Reddy SM, Gillespie SH, Husni ME, Scher JU, Salomon-Escoto K, Kay J, Luedders BA, Curtis JR, Shields AJS, Chakravarty SD, Gong C, Walsh JA. Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragmatic, phase 3b, open-label, randomized, controlled effectiveness trial. Trials. 2025 Mar 19; 26(1):96.